Ferring Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ferring Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014031
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ferring Pharmaceuticals Inc (Ferring), a subsidiary of Ferring International Center SA is a biopharmaceutical company that conducts research and development services. The company develops peptide-based drugs and biotechnology derived medicines. It also develops effective and patient-friendly drug delivery systems. Ferring’s products are used in the treatment of children who have growth failure, osteoarthritis knee pain, and others. The company research, develops and commercializes products in the therapeutic areas of orthopedics, endocrinology, urology, infertility and gastroenterology. Its research activities and products are connected by providing treatments. The company also operates research and development center, product development laboratories, and education and training center. It operates through manufacturing facilities located in Europe, South America, and Asia. Ferring is headquartered in Parsippany, New Jersey, the US.

Ferring Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women’s Health 10
Ferring Pharma Acquires Ddavp from Sanofi 11
Partnerships 12
Ferring Pharma Enters into Agreement with Intralytix 12
Ferring Pharma Enters into Co-Development Agreement with Roche 13
Acquisition 14
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 14
Ferring Pharmaceuticals Inc – Key Competitors 15
Ferring Pharmaceuticals Inc – Key Employees 16
Ferring Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 07, 2016: Ferring Pharmaceuticals opens Asia Pacific headquarters in Singapore 18
Corporate Communications 19
Jun 01, 2017: Paul Navarre Joins Ferring Pharmaceuticals as Chief Executive Officer of Ferring Holding 19
May 23, 2017: Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth 20
Mar 01, 2016: Ferring Names Aaron Graff as Chief Executive Officer of US Holding Company 21
Other Significant Developments 22
Feb 24, 2016: Healthcare Supply Chain Academy program launched by International Institute for the Management of Logistics in collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ferring Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ferring Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women's Health 10
Ferring Pharma Acquires Ddavp from Sanofi 11
Ferring Pharma Enters into Agreement with Intralytix 12
Ferring Pharma Enters into Co-Development Agreement with Roche 13
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 14
Ferring Pharmaceuticals Inc, Key Competitors 15
Ferring Pharmaceuticals Inc, Key Employees 16
Ferring Pharmaceuticals Inc, Subsidiaries 17

★海外企業調査レポート[Ferring Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chubb Limited:企業の戦略・SWOT・財務情報
    Chubb Limited - Strategy, SWOT and Corporate Finance Report Summary Chubb Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kazia Therapeutics Ltd (KZA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (A …
  • Southern Minnesota Municipal Power Agency:発電所・企業SWOT分析
    Southern Minnesota Municipal Power Agency - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • Tokuyama Corporation (4043):企業の財務・戦略的SWOT分析
    Tokuyama Corporation (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Restaurant Brands New Zealand Limited
    Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Vinci Construction UK Ltd:企業の戦略・SWOT・財務情報
    Vinci Construction UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Vinci Construction UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • China High Speed Transmission Equipment Group Co Ltd (658):電力:M&Aディール及び事業提携情報
    Summary China High Speed Transmission Equipment Group Co Ltd (CHSTE), a subsidiary of Five Seasons XVI Ltd, specializes in the production of high-speed and heavy-load transmission equipment. The company carries out research, design, development, manufacture and distribution of a broad range of mecha …
  • Nufarm Limited (NUF):企業の財務・戦略的SWOT分析
    Nufarm Limited (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Xcel Energy Inc (XEL):企業の財務・戦略的SWOT分析
    Xcel Energy Inc (XEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Healius Ltd (HLS):企業の財務・戦略的SWOT分析
    Healius Ltd (HLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MDxHealth SA (MDXH):医療機器:M&Aディール及び事業提携情報
    Summary MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The company’s products portfolio includes ConfirmMDx, which detects absence or presence of prostate cancer; SelectMDx for prost …
  • Follett Corporation:企業の戦略的SWOT分析
    Follett Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PsiOxus Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd, is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company's pipeline product portfolio includes an oncolytic vaccine and a dual action anabolic catabolic transf …
  • PT. Asuransi Jiwasraya (Persero):企業の戦略・SWOT・財務分析
    PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Transgene SA (TNG):企業の財務・戦略的SWOT分析
    Summary Transgene SA (Transgene) a subsidiary of Institut Merieux SA operates as a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develop …
  • Aratana Therapeutics Inc (PETX):企業の財務・戦略的SWOT分析
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • Ceconomy AG (CEC):企業の財務・戦略的SWOT分析
    Ceconomy AG (CEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, …
  • The Restaurant Group Plc:企業の戦略・SWOT・財務情報
    The Restaurant Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Restaurant Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆